Jagsonpal Pharmaceuticals Limited share price
NSE: JAGSNPHARM · ISIN INE048B01035
Key numbers
- Market cap
- ₹ 1,598 Cr
- Current price
- ₹ 242.29
- 52-week high / low
- ₹ 265 / 155
- Stock P/E
- 36.1
- Book value
- ₹ 39.4
- Dividend yield
- 1.03%
- ROCE
- 21.9%
- ROE
- 16.7%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 6.7%
- Profit growth (3 yrs)
- 17.3%
- 1-year return
- 3.0%
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 76 | 74 | 73 | 64 | 82 |
| Operating profit | 14 | 16 | 16 | 11 | 17 |
| Net profit | 11 | 13 | 11 | 9 | 13 |
| EPS (₹) | 1.60 | 1.88 | 1.67 | 1.25 | 2.00 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.